Covance

Covance and Sanofi-Aventis sign 10-year, $2.2 billion strategic R&D alliance

Thursday, September 30, 2010 09:52 AM

CRO Covance, based in Princeton, N.J., today announced the signing of definitive agreements with Sanofi-aventis for a research and development partnership worth up to $2.2 billion.

More... »

Covance Opens Biorepository in Indiana

Thursday, June 24, 2010 08:51 AM

Covance, a global contract research organization (CRO), has opened a state-of-the-art biorepository facility at its Greenfield, Ind. location.

More... »

CenterWatch Monthly June 2010

Thursday, June 3, 2010 08:38 AM

i3 Research, PPD, Kendle, Covance Rated Top CROs in Europe in 2010

More... »

Firecrest Clinical Appoints New CEO

Thursday, May 20, 2010 09:06 AM

Firecrest Clinical, an eClinical solution provider, announces the appointment of Alan Horgan as CEO.

More... »

Covance Launches Discovery and Translational Services Division

Monday, May 17, 2010 12:59 PM

Covance has reorganized its early-stage drug development work into a new division dedicated to discovery services, antibody products and immunology. The new group, Discovery and Translational Services, integrates the CRO’s Biomarker Center for Excellence, formed in 2009, with its Genomics Laboratory and existing partnerships with Caprion Proteomics and Rules-Based Medicine. 

More... »

Covance Profits Down 3% in Q1 as Central Lab Division Suffers Project Delays

Thursday, April 29, 2010 08:09 AM

Covance’s revenues grew and income fell in the first quarter of 2010. The company’s first quarter net revenues were $481.9 million, a 9.2% increase over the same period last year. Net income for the quarter fell 2.9% to $39.1 million, or $0.60 diluted EPS, compared with $40.3 million, or $0.63 diluted EPS, in Q1 2009.

More... »

Covance to Close Preclinical Site

Tuesday, April 20, 2010 06:41 AM

Covance is closing a testing site in Kalamazoo, Mich., as part of the CRO’s ongoing efforts to cut back its preclinical services. The site will be closed by November, and, according to published reports, 63 workers will lose their jobs.

More... »

Covance-Lilly Deal Continues to Bloom

Monday, March 15, 2010 06:51 AM

A little more than a year after Covance entered into a ground-breaking $1.6-billion drug development agreement with Eli Lilly, the contract research organization (CRO) continues to reap the awards of that deal and recently expanded the relationship.

More... »

Covance Revenue Up 8% in ‘09, Plans for 10% Growth in ‘10

Thursday, January 28, 2010 02:55 PM

Covance reported fourth-quarter revenue growth of 11% to $507 million, largely due to the positive impact of foreign exchange.

More... »

Unimed CRO Retools Name, Management

Friday, January 22, 2010 12:25 PM

Unimed, a contract research organization (CRO) in Prague, announced a name change and new management, following the final integration of its operations throughout Central and Eastern Europe.  The newly branded CRO—EastHORN—will continue to offer phase I to phase IV clinical trial services throughout the CEE region but plans to expand its reach to other countries within the region and perhaps as far as China and Africa in the future. The company has offices in Prague and Warsaw, as well as newly established offices in Bulgaria and Romania.

More... »